Profile data is unavailable for this security.
About the company
PT Soho Global Health Tbk is an Indonesia-based company. The Company operates in the healthcare sector. The Company operates through five segments: Distribution, Professional product, Consumer health, Alliance, and Others. Its brands include Curcuma Plus, Curcuma Plus Milk, Imboost, Fitkom, Diapet, Laxing, Lelap, Asthma Soho and Sohobion. Curcuma Plus is a kid’s multivitamin that contains curcuma and fish oil. Curcuma Plus Milk is a growing up milk for kids. Imboost is a supplement that supports immune system. Fitkom offers kids multivitamins in gummy and tablet format. Diapet is an anti-diarrheal medicine. Laxing is a medicine for healthy digestion and bowel movement. Lelap is a medicine to alleviate sleep disorders. Asthma Soho is an asthma remedy. Sohobion is a neurotropic vitamin supplement to maintain neurological health. The Company's product portfolio ranged from wound care, hospital general care, surgery, orthopedics, and in-vitro diagnostics.
- Revenue in IDR (TTM)9.64tn
- Net income in IDR442.79bn
- Incorporated--
- Employees2.31k
- LocationSoho Global Health Tbk PTJalan Jend. Sudirman Kav 27Mayapada 2 Building, 12th FloorJAKARTA TIMUR 12920IndonesiaIDN
- Phone+62 2 146832588
- Fax+62 2 146832589
- Websitehttps://sohoglobalhealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SNDL Inc | 10.28tn | -1.25tn | 8.21tn | 2.52k | -- | 0.6021 | -- | 0.7987 | -0.2998 | -0.2998 | 2.46 | 3.24 | 0.6062 | 4.98 | 36.38 | 257,643.70 | -7.61 | -24.44 | -8.22 | -27.94 | 25.69 | 22.49 | -12.55 | -62.17 | 4.16 | -- | 0.114 | -- | 27.63 | -- | 49.83 | -- | -- | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -1.20tn | 8.27tn | 507.00 | -- | 4.47 | -- | -- | -1.23 | -1.23 | 0.00 | 1.88 | 0.00 | -- | -- | 0.00 | -25.33 | -- | -32.84 | -- | -- | -- | -- | -- | 0.9619 | -- | 0.4548 | -- | -- | -- | 20.86 | -- | -- | -- |
| Pharming Group N.V. | 4.53tn | -282.60bn | 8.36tn | 415.00 | -- | 2.33 | -- | 1.84 | -0.0265 | -0.0265 | 0.4405 | 0.316 | 0.663 | 0.524 | 6.44 | 653,887.80 | -4.14 | 5.26 | -4.99 | 6.63 | 89.39 | 89.41 | -6.24 | 9.26 | 2.76 | -4.84 | 0.3601 | -- | 19.30 | 9.01 | -177.14 | -- | -13.04 | -- |
| Gufic BioSciences Ltd | 1.53tn | 162.12bn | 8.39tn | 1.45k | 51.23 | -- | 43.19 | 5.49 | 8.70 | 8.70 | 81.95 | -- | -- | -- | -- | 5,624,707.00 | -- | 11.46 | -- | 19.21 | 52.39 | 45.79 | 10.60 | 10.46 | -- | 8.09 | -- | 1.31 | 16.80 | 18.12 | 8.07 | 31.46 | 53.83 | 14.87 |
| Soho Global Health Tbk PT | 9.64tn | 442.79bn | 8.69tn | 2.31k | 19.63 | 3.35 | 17.02 | 0.9019 | 34.89 | 34.89 | 759.55 | 204.34 | 1.95 | 5.84 | 5.27 | 4,062,337,000.00 | 8.94 | 7.97 | 16.19 | 14.37 | 15.48 | 19.39 | 4.59 | 4.65 | 1.25 | -- | 0.0047 | -- | 12.45 | 12.43 | 4.10 | 49.70 | 21.21 | -- |
